Stem Cell Transplant Shows Success at HIV Remission in Fourth Patient 

August 3, 2022 by Alexa Hornbeck
Stem Cell Transplant Shows Success at HIV Remission in Fourth Patient 
A tray of stem cells at the University of Connecticut's Stem Cell Institute at the UConn Health Center on August 27, 2010, in Farmington, Conn. (Spencer Platt/Getty Images/TNS) **FOR USE WITH THIS STORY ONLY**

One of the largest cancer research and treatment organizations in the United States, known as City of Hope, announced on July 27 that a fourth patient, who has the longest diagnosis of HIV yet, has gone into remission after receiving a blood stem cell transplant from a donor with a rare genetic mutation. 

The 66-year-old man was diagnosed with HIV in 1988 and took an antiretroviral therapy for over 30 years.


It’s been three years following his stem cell transplant, but the man has now been in remission of the virus for over 17 months and is able to stop taking the antiretroviral therapy.


According to physicians from City of Hope, the patient has a high risk for relapsing from acute myeloid leukemia, making his remission even more remarkable. 


Alexa can be reached at [email protected]

A+
a-

In The News

Health

Voting

Health

August 18, 2022
by Dan McCue
Columbia University Study Reveals New Causes of Common Lymphoma

NEW YORK — Cancer researchers at Columbia University in New York have found a multitude of new genetic mutations that... Read More

NEW YORK — Cancer researchers at Columbia University in New York have found a multitude of new genetic mutations that cause a common type of lymphoma. “Our findings not only show that these mutations can contribute to diffuse large B cell lymphoma, but they identify an... Read More

August 17, 2022
by Dan McCue
CDC Director Calls for Agency Reorganization After External Review

ATLANTA — Dr. Rochelle Walensky, the director of the Centers for Disease Control and Prevention, is calling for a dramatic... Read More

ATLANTA — Dr. Rochelle Walensky, the director of the Centers for Disease Control and Prevention, is calling for a dramatic reorganization of the agency in the wake of an external review of the agency’s handling of the coronavirus pandemic. In a meeting with senior staff, Walensky... Read More

Planned Parenthood to Spend Record $50M in Midterm Elections

WASHINGTON (AP) — Planned Parenthood, the nation's leading reproductive health care provider and abortion rights advocacy organization, plans to spend... Read More

WASHINGTON (AP) — Planned Parenthood, the nation's leading reproductive health care provider and abortion rights advocacy organization, plans to spend a record $50 million ahead of November's midterm elections, pouring money into contests where access to abortion will be on the ballot. The effort, which breaks the... Read More

August 16, 2022
by TWN Staff
Monoclonal Antibody Reduces Asthma Attacks in Urban Youth

WASHINGTON — A monoclonal antibody, mepolizumab, decreased asthma attacks by 27% in Black and Hispanic children and adolescents who have... Read More

WASHINGTON — A monoclonal antibody, mepolizumab, decreased asthma attacks by 27% in Black and Hispanic children and adolescents who have a form of severe asthma, are prone to asthma attacks and live in low-income urban neighborhoods, a National Institutes of Health clinical trial has found.  The... Read More

August 16, 2022
by TWN Staff
WHO Releases Updated Guidance on Planning for Tuberculosis

GENEVA, Switzerland — The World Health Organization released a new guidance on Tuesday to support national strategic planning for the... Read More

GENEVA, Switzerland — The World Health Organization released a new guidance on Tuesday to support national strategic planning for the tuberculosis response. The guidance encourages the use of a people-centric focus in the development of a national TB strategic plan. It also highlights the importance of... Read More

August 16, 2022
by TWN Staff
Baylor Receives Grant to Study Liver Cancer Risk and Prevention

HOUSTON — Researchers at Baylor College of Medicine received a five-year, $5.5 million-plus grant from the National Cancer Institute for... Read More

HOUSTON — Researchers at Baylor College of Medicine received a five-year, $5.5 million-plus grant from the National Cancer Institute for research on liver cancer risk factors and prevention, with the goal of reducing the burden of liver cancer in patients with metabolic dysfunction. “The population of... Read More

News From The Well
scroll top